The Medicines Company

The Medicines Company Q2 2008 Earnings Conference Call Transcript (at Seeking Alpha)

yahoo.com     16 hrs ago   19 related          

posted on: July 23, 2008 | about stocks: MDCO Q2 2008 Earnings Call Transcript Executives Robyn Brown – VP, IR Clive Meanwell – Chairman and CEO Glenn Sblendorio – EVP and CFO John Kelley – President and COO Analysts Maged...                

comments

                   

The Medicines Company Q2 2008 Earnings Conference Call Transcript

seekingalpha.com     16 hrs ago   497 related          

posted on: July 23, 2008 | about stocks: MDCO Q2 2008 Earnings Call Transcript Executives Robyn Brown – VP, IR Clive Meanwell – Chairman and CEO Glenn Sblendorio – EVP and CFO John Kelley – President and COO Analysts Maged...                

comments

                   

For Amgen's Nplate, No News is Good News

invivoblog.blogspot.com     15 hrs ago   14 related          

In case you didn’t have it circled on your calendar, July 23 is the user fee deadline for Amgen’s romiplostim (Nplate). And according to Amgen, FDA won’t be picking up the phone today with a final answer on the platelet...                

comments

The Medicines Company Reports Second Quarter and First Half 2008 Financial Results and Raises...

yahoo.com     yesterday   43 related          

Wednesday July 23, 8:00 am ET PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO - News ) today announced its financial results for the second quarter and first half of 2008. 1Excluding stock-based...                

comments

New Publication Shows Cleviprex?Is Effective For Rapid Treatment Of Acute Hypertension After...

studentbmj.com     Jul 21, 2008          

The Medicines Company (NASDAQ:-MDCO) announced that the results of ESCAPE-2, a pivotal Phase 3 efficacy trial of its investigational agent Cleviprex?(clevidipine butyrate) injectable emulsion, were published in the July issue...                

comments

New Publication Shows Cleviprex is Effective for Rapid Treatment of Acute Hypertension After...

drugs.com     Jul 17, 2008          

PARSIPPANY, N.J.--(BUSINESS WIRE)--Jul 14, 2008 - The Medicines Company (NASDAQ: MDCO) today announced that the results of ESCAPE -2, a pivotal Phase 3 efficacy trial of its investigational agent Cleviprex(TM) (clevidipine...                

comments

New Publication Shows Cleviprex™ Is Effective For Rapid Treatment Of Acute Hypertension After...

medicalnewstoday.com     Jul 15, 2008   2 related          

The Medicines Company (NASDAQ: -MDCO) announced that the results of ESCAPE -2, a pivotal Phase 3 efficacy trial of its investigational agent Cleviprex™ (clevidipine butyrate) injectable emulsion, were published in the July...                

comments

                   

Sarah Larson: I showed those bikini wrestling pics to Clooney before they hit ‘net

celebitchy.com     Jul 12, 2008   1 related          

I got the chance to read Sarah Larson’s full interview with Hello! Magazine and it has a couple of gems that I haven’t read elsewhere. Other outlets focused on Larson’s claims that she’s still friends with Clooney, that she...                

comments

The Medicines Company to Announce Second Quarter 2008 Financial Results on Wednesday, July 23, 2008

redorbit.com     Jul 10, 2008   63 related          

The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, July 23, 2008 at 8:30 a.m. Eastern Time to discuss second quarter 2008 financial results, guidance and operational developments....                

comments

Tongjitang To Host Conference Call (Business Wire)

yahoo.com     Jul 7, 2008          

SHENZHEN, China----Tongjitang Chinese Medicines Company , a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today...                

comments

1 2 3 4 5 next »